Newsletter Signup | Join Community
PI3K inhibitors are a promising new therapy for the management of b cell lymphomas and are being evaluated in MZL.
FDA Approves Chemoimmunotherapy Regimen for Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma
Ten things every patient with lymphoma should consider in order to get the best possible treatment
Treatment of Marginal Zone Lymphomas: MALT Lymphomas, Splenic and Marginal Zone Lymphomas. FDA approves Revlimid-Rituxan
What you need to know about CAR T cell therapy for the treatment of lymphoma, leukemia and solid tumors.
Lymphoma is a curable cancer and this continues to improve with newer precision medicines and immuntherapy
Superior court jury decides NHL was at least partly caused by glyphosate, an ingredient in RoundUp. US EPA Disagrees
How long have people been on watch and wait before they needed treatment ?
Rituxan Maintenance; has your doctor recommended it every 2 or every 3 months?
Long-Term Follow-Up Indicates Survival with Addition of Rituxan® to CHOP in NHL
Curious is others with celiac disease have develeoped lymphoma? https://mavendoctors…